Life Sciences Transactions
ALG has Ireland’s leading life sciences transactions practice. Our dedicated team is consistently at the centre of the most high-profile and strategic deals in the market. We advise a broad range of clients including Irish, US, and international companies—across the full spectrum of trade and private equity life sciences transactions. These include acquisitions, bolt-ons, disposals, fundraisings, IPOs, spin-offs, collaborations, and a wide variety of royalty and commercial arrangements.
ALG has a full team of life sciences specialists in regulatory, IP, data, commercial, employment, tax, and health and safety. This ensures our clients receive expert advice across the board, on their key strategic transactions.
ALG has close relationships with Irish governmental authorities, regulators, and the international advisory community in the sector. Clients value our full service offering and have trusted us to deliver for them over many decades.
Our experience
Exponent Private Equity on its acquisition of Chanelle Pharma, the largest indigenous pharma company in Ireland and the largest manufacturer of human and veterinary generic pharmaceuticals.
Endo Pharmaceuticals on its successful exit from a US Chapter 11 restructuring and on its pending $6.7bn merger of equals with Mallinckrodt.
Solventum Inc. on the Irish aspects of the $4.1bn sale of its purification and filtration business to Thermo Fisher.
Novartis on the sale of its Irish manufacturing facility to Sterling Pharma.
Nabriva Therapeutics on various asset disposals to Sumitomo and to Meitheal Pharma.
ICON on its $12bn acquisition of PRA Health Sciences group.
Integer on the acquisition of Aran Biomedical.
Xeris Pharmaceuticals on its public takeover of Strongbridge Biopharma plc.
UDG Healthcare on its acquisition by Clayton, Dubilier & Rice.
Key contacts
Deirdre Geraghty
Partner, Corporate and M&A, New York
©2025 A&L Goodbody LLP
All rights reserved